Related Experiment Videos
Beta blocker dose-titration in the drug treatment of hypertension
The New Zealand Medical Journal
|September 12, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A questionnaire survey of symptoms in a hypertension clinic.
The New Zealand medical journal·1990
Changes in clinical characteristics and drug treatment of hypertension over 40 years at the Dunedin Hypertension Clinic.
Journal of cardiovascular pharmacology·1990
Risk predictors in treated hypertension.
Journal of cardiovascular pharmacology·1990
Twenty-four-hour ambulatory blood pressure pattern in youngsters with a different family history of hypertension: the Dutch Hypertension and Offspring Study.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension·1989
Eight-year survival study of treated hypertension at the Dunedin Hypertension Clinic 1953-1977.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension·1988
Highlighting the push and the pull: a comparison of New Zealand and United Kingdom resident doctor contracts.
The New Zealand medical journal·2026
A retrospective observational study of on-call hospital pharmacist activities in a rural setting in Aotearoa New Zealand.
The New Zealand medical journal·2026
Māori notified with tuberculosis in one public health region of Aotearoa New Zealand: a document review.
The New Zealand medical journal·2026
Effectiveness of selective laser trabeculoplasty for glaucoma and ocular hypertension in a large real-world cohort in New Zealand.
The New Zealand medical journal·2026
Current perspectives in the pharmacological management of cutaneous and mucosal leishmaniasis.
Expert opinion on pharmacotherapy·2026
New potassium binders: we need them-we do not need them.
Clinical kidney journal·2026
Pharmacologic Treatment of Obesity in Adults: Standards of Care in Overweight and Obesity.
Diabetes, obesity, and cardiometabolic CARE·2026
Ibogaine for Substance Use Disorders.
Advances in therapy·2026